Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

COVID-19 GPH|Home|PHGKB Last data update: Jan 20, 2021 . (Total: 19105 Documents since 2020)

Last Posted: Jan-20-2021 07:13:36
spot light Spotlight

COVIDTracer and COVIDTracer Advanced
CDC, January 19, 2021

COVIDTracer and COVIDTracer Advanced are spreadsheet-based tools that allow state- and local-level public health officials and policy makers to compare the effectiveness, and the resources needed, of three user defined contact tracing and monitoring strategies.

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Z Wang et al, BIORXIV, January 19, 2021

We report on the antibody and memory B cell responses in a cohort of 20 volunteers who received mRNA vaccines. Consistent with prior reports, 8 weeks after the second vaccine injection volunteers showed high levels of IgM, and IgG anti-SARS-CoV-2 spike protein (S), receptor binding domain (RBD) binding titers. However, activity against SARS-CoV-2 variants encoding E484K or N501Y or the K417N:E484K:N501Y combination was reduced by a small but significant margin.

Face masks help control transmission of COVID-19
HE Clapham et al, Lancet Infectious Diseases, January 19, 2021

The evidence is clear: masks work. However, their use is a non-targeted control measure, wherein the whole population is involved, rather than just known or suspected cases. Buy-in from society is necessary for the success of the intervention.

Airborne Transmission of SARS-CoV-2: What We Know.
Samet Jonathan M et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Jan

We examine airborne transmission of SARS-CoV-2 potential using a source-to-dose framework beginning with generation of virus-containing droplets and aerosols and ending with virus deposition in the respiratory tract of susceptible individuals. By addressing four critical questions, we identify both gaps in addressing four critical questions with answers having policy implications.

news Latest News and Publications
Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity
Y Jia et al, BORXIV, January 19, 2021

New Added Today

Distinct Patterns of Emergence of SARS-CoV-2 Spike Variants including N501Y in Clinical Samples in Columbus Ohio
H Tu et al, BIORXIV, January 19, 2021

New Added Today

SARS-CoV-2 Genomic Surveillance in Costa Rica: Evidence of a Divergent Population and an Increased Detection of a Spike T1117I Mutation
JA Molina et al, BIORXIV, January 19, 2021

New Added Today

A big-data driven approach to analyzing and modeling human mobility trend under non-pharmaceutical interventions during COVID-19 pandemic.
Hu Songhua, et al. Transportation research. Part C, Emerging technologies 2021 3 0. 102955

New Added Today

Smart technologies driven approaches to tackle COVID-19 pandemic: a review.
Khan Hameed, et al. 3 Biotech 2021 2 0. (2) 50

New Added Today

Automated processing of social media content for radiologists: applied deep learning to radiological content on twitter during COVID-19 pandemic.
Khurana Shikhar, et al. Emergency radiology 2021 1 0.

New Added Today

Deep Learning Models for Predicting Severe Progression in COVID-19-infected Patients.
Ho Thao Thi, et al. JMIR medical informatics 2021 1 0.

New Added Today

Digital contact tracing for COVID-19 epidemic emergency management-A case study based on graph database algorithm.
Mao Zijun, et al. JMIR mHealth and uHealth 2021 1 0.

New Added Today

Optimization using the firefly algorithm of ensemble neural networks with type-2 fuzzy integration for COVID-19 time series prediction.
Melin Patricia, et al. Soft computing 2021 1 0. 1-38

New Added Today

On the reliability of predictions on Covid-19 dynamics: A systematic and critical review of modelling techniques.
Gnanvi Janyce, et al. Infectious Disease Modelling 2021 1 0.

New Added Today

All Latest

Sign up Email Alert

Content Statistics

  • Total (19105)
  • Genomics Precision Health (15532)
  • Non-Genomics Precision Health (3569)

About COVID-19 GPH

COVID-19 GPH is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that captures emerging discoveries and applications of genomics, molecular and other precision medicine and precision public health tools in the investigation and control of COVID-19. Contents include PubMed records via an automated pubmed search algorithm, preprint records from NIH iCite, the relevant information from many media sources picked by experts, and linkages to contents from our curated PHGKB databases.

Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations involving COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science and machine learning methods (not involving genomics) in discovery, clinical and public health investigations involving COVID-19

Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.